BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32675558)

  • 1. Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
    SahBandar IN; Chew GM; Corley MJ; Pang APS; Tsai N; Hanks N; Khadka VS; Klatt NR; Hensley-McBain T; Somsouk M; Vujkovic-Cvijin I; Chow DC; Shikuma CM; Ndhlovu LC
    AIDS; 2020 Aug; 34(10):1451-1460. PubMed ID: 32675558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade.
    Chew GM; Padua AJP; Chow DC; Souza SA; Clements DM; Corley MJ; Pang APS; Alejandria MM; Gerschenson M; Shikuma CM; Ndhlovu LC
    AIDS Res Hum Retroviruses; 2021 Jan; 37(1):24-33. PubMed ID: 33019813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
    J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.
    Clements DM; Crumley B; Chew GM; Davis E; Bruhn R; Murphy EL; Ndhlovu LC; Jain P
    Front Immunol; 2021; 12():608890. PubMed ID: 33767694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
    de Armas LR; Pallikkuth S; Rinaldi S; Pahwa R; Pahwa S
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1112-1122. PubMed ID: 31578868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques.
    Hensley-McBain T; Zevin AS; Manuzak J; Smith E; Gile J; Miller C; Agricola B; Katze M; Reeves RK; Kraft CS; Langevin S; Klatt NR
    J Virol; 2016 May; 90(10):4981-4989. PubMed ID: 26937040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression.
    Basilissi M; Tincati C; Merlini E; Ancona G; Borghi E; Borgo F; Barassi A; d'Arminio Monforte A; Marchetti G
    PLoS One; 2019; 14(2):e0212075. PubMed ID: 30763359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
    Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
    Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
    Ellis CL; Ma ZM; Mann SK; Li CS; Wu J; Knight TH; Yotter T; Hayes TL; Maniar AH; Troia-Cancio PV; Overman HA; Torok NJ; Albanese A; Rutledge JC; Miller CJ; Pollard RB; Asmuth DM
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):363-70. PubMed ID: 21436711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
    Lau JSY; McMahon JH; Gubser C; Solomon A; Chiu CYH; Dantanarayana A; Chea S; Tennakoon S; Zerbato JM; Garlick J; Morcilla V; Palmer S; Lewin SR; Rasmussen TA
    AIDS; 2021 Aug; 35(10):1631-1636. PubMed ID: 33859108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function.
    Brunet-Ratnasingham E; Morou A; Dubé M; Niessl J; Baxter AE; Tastet O; Brassard N; Ortega-Delgado G; Charlebois R; Freeman GJ; Tremblay C; Routy JP; Kaufmann DE
    EBioMedicine; 2022 Oct; 84():104254. PubMed ID: 36150362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer.
    Ren S; Feng L; Liu H; Mao Y; Yu Z
    Thorac Cancer; 2024 May; 15(14):1149-1163. PubMed ID: 38572783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
    Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
    J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
    Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
    BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
    Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
    Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.
    Vujkovic-Cvijin I; Rutishauser RL; Pao M; Hunt PW; Lynch SV; McCune JM; Somsouk M
    Gut Microbes; 2017 Sep; 8(5):440-450. PubMed ID: 28541799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.